Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
The company’s in-vitro diagnostic test help urologists detect bladder cancer earlier.
eSense recently signed a deal to develop a beer product line that is infused with terpenes.
The company's shares are trading 4% higher intra-day, at $0.26.
The company recently completed stage I of its medicinal cannabis growing facility in Queensland.
Phase II clinical study results have revealed excellent safety and tolerability.
New funds will support the commercial launch of the technology.
Drug sales for head and neck cancer treatment projected to rise to $1.53 billion in 2024.
An important proposed change for MMJ’s largest investment, Harvest One Cannabis Inc.